FDA inspection
Eriochem facilities have been inspected and accepted by the FDA
From 26 May to 3 June 2014, he received a GMP inspection Eriochem FDA United States for API already registered in that market (vinorelbine tartrate) and two new pharmaceuticals (Docetaxel and Melphalan).
As a result of such inspection in October 2014, the General Manager of the company received a letter from the FDA stating that the laboratory facilities were considered acceptable based on the inspection report.
